GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 2 analysts with an average price target of $37.82. This is a potential upside of $-6.09 (-13.87%) from yesterday's end of day stock price of $43.91.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 151 price targets and 95 ratings on display. The stock rating distribution of GSK is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.73% with an average time for these price targets to be met of 463.5 days.

Highest price target for GSK is $41, Lowest price target is $41, average price target is $41.

Most recent stock forecast was given by KERRY HOLFORD from BERENBERG on 01-Dec-2024. First documented stock forecast 27-Jul-2014.

Currently out of the existing stock ratings of GSK, 1 are a HOLD (50%), 1 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$41

$-2.54 (-5.83%)

10 months 16 days ago
(01-Dec-2024)

1/1 (100%)

$7.82 (23.57%)

182

Hold

$53

11 months 6 days ago
(11-Nov-2024)

3/5 (60%)

$16.8 (46.41%)

323

Buy

1 years 2 months 17 days ago
(31-Jul-2024)

0/13 (0%)

$-16.49 (-43.22%)

Buy

$45

$1.46 (3.35%)

$47

1 years 3 months 2 days ago
(15-Jul-2024)

2/3 (66.67%)

$8.15 (22.12%)

976

Buy

$19.52

1 years 8 months 5 days ago
(12-Feb-2024)

0/3 (0%)

$-12.79 (-39.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 463.5 days on average for the stock forecasts to be realized with a an average price target met ratio 28.73

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

STEVE SCALA

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Steve Scala works at TD COWEN and has 26 price targets and 15 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

John Eade with highest potential upside - $1.46

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Emily Field with lowest potential downside - -$27.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?